Regional and facility disparities in androgen deprivation therapy for prostate cancer from a multi-institutional Japan-wide database.
Masaki ShiotaRyota SumikawaMizuki OnozawaShiro HinotsuYasuhide KitagawaShinichi SakamotoTaketo KawaiMasatoshi EtoHaruki KumeHideyuki Akazanull nullPublished in: International journal of urology : official journal of the Japanese Urological Association (2021)
Our findings suggest that Japan facility type, but not geographical regions, might affect the prognosis of prostate cancer patients receiving primary androgen deprivation therapy.